نتایج جستجو برای: benign prostatic hyperplasia bph

تعداد نتایج: 129007  

Journal: :Clinics in geriatric medicine 2010
David R Paolone

This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies. The management includes medical and surgical options. Medical options include alpha-1-adrenergic rec...

Journal: :In vivo 2004
Dimitrios Stefanou Anna Batistatou Sevasti Kamina Evdokia Arkoumani Dionysios J Papachristou Niki J Agnantis

BACKGROUND Tumor angiogenesis is an absolute requirement for tumor growth and a prognostic factor for various malignant neoplasms. Recent reports in the literature have addressed the importance of the VEGF system in benign prostatic hyperplasia (BPH) and adenocarcinoma, however the results are controversial. The aim of the present study was to determine and compare the levels of VEGF expression...

Journal: :South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2006
Zoltan Bereczky Mike Bolus Preg Chetty Wim du Toit Jan Enslin Mohamed Haffejee Chris Heyns David Hyams Dian Kirstein Murray Mackenzie Abel Mamine Shingai Mutambirwa Barry Niemand Chris Opperman Alan Pontin Simon Reif Ferdi Sauer Alfred Segone David Smart Pieter Steenkamp Golda Stellmacher Frans van Wijk Schalk Wentzel

Benign prostatic hyperplasia (BPH) is one of the most common conditions affecting older men. Strictly speaking, BPH is a histological diagnosis, and the term benign prostatic enlargement (BPE) is used when there is detectable enlargement of the prostate that is clinically not malignant. As a result of BPH, as many as 1 in 3 men over the age of 45 experience bothersome lower urinary tract sympto...

Journal: :Medical Devices : Evidence and Research 2021

Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) are highly prevalent in older men. The long-term clinical utility of lifestyle modification and oral medications for LUTS is limited. There a great need safe, effective, durable BPH therapies men who unsuccessfully attempt conservative measures. Enthusiasm transurethral resection the prostate has declined due su...

Journal: :International Journal of Homoeopathic Sciences 2023

A condition known as benign prostatic hyperplasia (BPH), which causes the prostate gland to grow, raises risk of kidney, bladder, and urinary tract disorders. This can progress acute retention, is commonly seen in men over age 60. More than 30% suffer from BPH. As age, will increase slightly almost all them. Approximately 90% males experience symptoms by time they are 85. The majority these tha...

Journal: :Clinical biochemistry 2006
Ahmet Aydin Zorica Arsova-Sarafinovska Ahmet Sayal Ayse Eken Onur Erdem Koray Erten Yaşar Ozgök Aleksandar Dimovski

OBJECTIVES We undertook the present study to investigate the possible alteration of oxidant/antioxidant status in the circulation of patients with prostate cancer and benign prostatic hyperplasia. DESIGN AND METHODS Thiobarbituric acid reactive substances (TBARS), the enzyme activities of superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase (CAT) and copper (Cu) and zinc (Zn) le...

2013
Yu-Na Kim Min-Sun Kim Sung-Sik Chun Jeong-Hwa Choi

Benign prostatic hyperplasia (BPH) is one of the most common diseases among elderly men. As the old-age population is increasing recently, it is to our interest to observe the growing BPH within them. In BPH, the dihydrotestosterone (DHT) acts as promotes prostate growth. It inhibits enzyme 5α-reductase that is involved in the conversion of testosterone to the DHT activity which reduces the exc...

Journal: :Uro 2022

Increased risk of prostate diseases triggered by testosterone replacement therapy (TRT) remains a worldwide concern. That said, we reviewed the safety TRT in spheres benign prostatic hyperplasia (BPH) and cancer (PCa), exploring clinical findings this regard. Compelling evidence based on meta-analyses randomized observational studies indicates for patients suffering from disorders such as BPH P...

2015
Ekaterina A. Lesovaya Kirill I. Kirsanov Elena E. Antoshina Lubov S. Trukhanova Tatiana G. Gorkova Elena V. Shipaeva Ramiz M. Salimov Gennady A. Belitsky Mikhail V. Blagosklonny Marianna G. Yakubovskaya Olga B. Chernova

Benign prostatic hyperplasia (BPH) is the most common age-related disease in men. Here we tested the efficacy of Rapatar, a micellar nanoformulation of rapamycin, in two rat models of BPH: testosterone-induced and sulpiride-induced hyperplasia in ventral lobes and lateral/dorsal lobes, respectively. We found that Rapatar prevented hypertrophic and hyperplastic abnormalities and degenerative alt...

Journal: :Genitourinary medicine 1996
M N al-Ahdal A H Kardar A M Selim G Kessie

Human papillomavirus, type 16 (HPV-16) and type 18 (HPV-1 8) are known to play a role in the development of neoplastic disorders of the urogenital organs. The presence of HPV-1 6 and HPV18 in prostatic tissue with benign hyperplasia has been a matter of controversy. Some investigators have reported a high prevalence of HPV-16 DNA and a low prevalence of HPV-18 DNA in prostatic tissue,'-3 while ...

20042005200620072008200920102011201220132014201520162017201820192020202120222023050001000015000

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید